BiotechTube
Home/Compugen/Anat Cohen-Dayag, Ph.D.
AC

Anat Cohen-Dayag, Ph.D.

President, CEO & Director

Compugen

Therapeutic Areas

OncologyImmuno-oncology

Compugen Pipeline

DrugIndicationPhase
COM701Solid Tumors (e.g., Platinum-Resistant Ovarian Cancer)Phase 1/2
COM902Solid TumorsPhase 1/2
BAT5506Undisclosed Solid TumorsPreclinical

Leadership Team at Compugen

HA
Henry Adewoye, M.D.
Chief Medical Officer
EN
Eran Natanson
Chief Financial Officer
JP
Joshua P. Pustilnik, Ph.D.
SVP, Corporate Development
MD
Michele D. Korfin
COO & Chief Commercial Officer
MG
Martin Gerrits
Chair of the Board
View full Compugen profile